GB927288A - 1-and 7-(basically-substituted-alkyl) xanthine derivatives, a process for their manufacture and pharmaceutical compositions containing them - Google Patents

1-and 7-(basically-substituted-alkyl) xanthine derivatives, a process for their manufacture and pharmaceutical compositions containing them

Info

Publication number
GB927288A
GB927288A GB31890/59A GB3189059A GB927288A GB 927288 A GB927288 A GB 927288A GB 31890/59 A GB31890/59 A GB 31890/59A GB 3189059 A GB3189059 A GB 3189059A GB 927288 A GB927288 A GB 927288A
Authority
GB
United Kingdom
Prior art keywords
radical
alkyl
basically
substituted
manufacture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB31890/59A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CHEMIEWERK HOMBURG ZWEIGNIEDER
Evonik Operations GmbH
Original Assignee
CHEMIEWERK HOMBURG ZWEIGNIEDER
Deutsche Gold und Silber Scheideanstalt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CHEMIEWERK HOMBURG ZWEIGNIEDER, Deutsche Gold und Silber Scheideanstalt filed Critical CHEMIEWERK HOMBURG ZWEIGNIEDER
Publication of GB927288A publication Critical patent/GB927288A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • A61K31/522Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/10Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 3 and 7, e.g. theobromine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/18Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB31890/59A 1958-10-18 1959-09-18 1-and 7-(basically-substituted-alkyl) xanthine derivatives, a process for their manufacture and pharmaceutical compositions containing them Expired GB927288A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1958C0017685 DE1123329B (de) 1958-10-18 1958-10-18 Verfahren zur Herstellung von basisch substituierten Alkylxanthinderivaten.

Publications (1)

Publication Number Publication Date
GB927288A true GB927288A (en) 1963-05-29

Family

ID=7016288

Family Applications (1)

Application Number Title Priority Date Filing Date
GB31890/59A Expired GB927288A (en) 1958-10-18 1959-09-18 1-and 7-(basically-substituted-alkyl) xanthine derivatives, a process for their manufacture and pharmaceutical compositions containing them

Country Status (4)

Country Link
CH (1) CH379511A (enrdf_load_stackoverflow)
DE (1) DE1123329B (enrdf_load_stackoverflow)
FR (1) FR479M (enrdf_load_stackoverflow)
GB (1) GB927288A (enrdf_load_stackoverflow)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3245994A (en) * 1966-04-12 Theophylline derivatives
DE1221641B (de) * 1962-03-30 1966-07-28 Degussa Verfahren zur Herstellung von basisch substituierten Theophyllinderivaten
DE1237578B (de) * 1963-05-10 1967-03-30 Knoll Ag Verfahren zur Herstellung basisch substituierter Xanthinderivate

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1011424B (de) * 1954-04-17 1957-07-04 Chemiewerk Homburg Ag Verfahren zur Herstellung von basisch substituierten 7-Alkyl-xanthinderivaten oder deren Salzen

Also Published As

Publication number Publication date
CH379511A (de) 1964-07-15
FR479M (enrdf_load_stackoverflow) 1961-05-02
DE1123329B (de) 1962-02-08

Similar Documents

Publication Publication Date Title
DE3567870D1 (en) Xanthine derivatives, processes for their preparation and pharmaceutical compositions containing them
HUT42095A (en) Process for producing purine ring or analogue ring-systhems /heteropurine/-containing compounds and pharmaceutical compositions containing them
FI900085A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten N-(pyrimidin- ja kondensoitu pyrimidin-4-oni)etyyli-piperidiini- ja piperatsiinijohdannaisten valmistamiseksi
ES8306160A1 (es) "procedimiento para preparar un nuevo compuesto de cefem".
DK651288D0 (da) Pyridazinaminderivater, fremgangsmaade til fremstilling deraf samt praeparater indeholdende samme
GB970886A (en) New pyridines and process for the manufacture thereof
ES2045083T3 (es) Un procedimiento para preparar un compuesto quimico.
ES8300774A1 (es) Un procedimiento para preparar nuevos compuestos de cefem
PT87277A (pt) Process for the preparation of new bicyclic compounds and pharmaceutical compositions comprising same
PL249964A1 (en) Process for preparing novel derivatives of 7-//z/-2-/2-aminothiazolyl-4/-2-oxyiminoacetamide/-3-cephemo-4-carboxylic acid
ATE2330T1 (de) 3,7-disubstituierte-2- oder -3-cephem-4carbons[ure-verbindungen, sie enthaltende pharmazeutische zusammensetzungen und verfahren zu deren herstellung.
GB824908A (en) Improvements in or relating to triazine derivatives
GB989013A (en) New guanidines and process for their manufacture
GB927288A (en) 1-and 7-(basically-substituted-alkyl) xanthine derivatives, a process for their manufacture and pharmaceutical compositions containing them
DE3367215D1 (en) Pyridobenzodiazepinones, process for their preparation and pharmaceutical compositions containing them
GB1084150A (enrdf_load_stackoverflow)
HUT36799A (en) Process for producing cepheme-carboxylic acid derivatives and pharmaceutical compositions containing them
GB1407856A (en) Anti-inflammatory thiazole compositions and methods for using same
ES8801637A1 (es) Un procedimiento para la preparacion de benzimidazoles.
SE8303719L (sv) Eburnan-oximderivat, forfarande for framstellning derav samt farmaceutiska kompositioner innehallande dessa foreningar
GB1469430A (en) Daunomycin derivatives
GB1017450A (en) 2-amino-4-alkoxy-úË-triazines
GB1318859A (en) Imidazo-4,5-b-pyridine derivatives
HU904214D0 (en) Process for producing pyrrolo(2,1-b)thiazole derivatives
GB1284582A (en) Substituted piperazinopyrimidinones